期刊文献+

中西医结合治疗小儿原发性肾病综合征的临床观察 被引量:7

Clinical Observation of Chinese and Western Medicine Combination for Primary Nephrotic Syndrome in Children
下载PDF
导出
摘要 目的探讨中西医结合治疗原发性小儿肾病综合征(PNS)的有效方法。方法原发性肾病综合征患儿80例按照治疗方法不同分为:中西医结合组(A组)40例,西医治疗组(B组)40例,测定治疗前后PNS患儿的血清脂质水平血清胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)水平变化,比较两组疗效及不良反应。结果A组总有效率95.0%,明显高于B组82.5%(χ2=4.24,P<0.05);A组治疗后TC、TG、HDL-C、LDL-C含量均高于B组(t=2.220,t=2.307,t=2.344,t=2.319,P<0.05);A组不良反应发生率6例(7.5%)低于B组9例(11.2%)(χ2=3.89,P<0.05)。结论中西医结合治疗原发性小儿肾病综合征明显优于单纯西药治疗。 Objective To explore an effective way to the treatment of primary nephrotic syndrome (PNS) by combining Chinese and Western medicine. Methods We divided 80 cases of PNS in children according to different treatment ways into: Chinese and Western medicine combination group(Group A, 40 cases) and Western medicine group(Group B, 40 cases). The serum levels of cholesterol (TC), triglyccrides (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were measured before and after treatment. The curative efficacy and adverse reactions were compared between the two groups. Results The total effective rate of Group A was 95.0%, significantly higher than that(82.5%) of Group B( χ^2=4.24, P〈0.05). The serum levels of TC, TG, HDL-C and LDL-C in Group A after treatment were higher than those of Group B(t=2.220, t=2.307, t=2.344, t=-2.319 ,P〈0.05). The adverse reactions of Group A(6 cases,7.5%) were significantly lower than those of Group B(11.2%)(χ^2=3.89,P〈0.05). Conclusion The curative effect of Chinese and Western medicine combination in the treatment of children with PNS is superior to that of Western medicine alone.
作者 李馥媛
出处 《中国现代医生》 2010年第4期66-67,共2页 China Modern Doctor
关键词 原发性肾病综合征 小儿 中西医结合 Primary nephrotic syndrome Children Combination of Chinese and Western medicine
  • 相关文献

参考文献6

二级参考文献30

  • 1陈双华,叶任高,李惠群.中西医结合治疗肾炎性肾病综合征的临床观察[J].中华肾脏病杂志,1995,11(6):357-360. 被引量:85
  • 2第二届全国肾脏病学术会议修正修订肾小球疾病临床分型意见[J].中华肾脏病杂志,1985,1(1):12-14. 被引量:2
  • 3Keane W F, Mulcanhy W S,Kasiske B L,et al. Hyperlipidemia and progressive renal disease[J].Kidney Int suppl,1991,31:41. 被引量:1
  • 4Thabet M A, Salcedo Jr, Chan J C, et al Hyperlipidemia in childhood nephritic syndrome [J]. Pediatr Nephrol,1993,7:559. 被引量:1
  • 5Attman P O and Alaupovic P. Pathogenesis of hyperlipidemia in the nephritic syndrome [J]. Am J Nephrol,1990,10(Suppl):69. 被引量:1
  • 6Amico G D. Lipid changes in the nephritic syndrome:New insights into pathomechanisms and treatment [J].Klin Wochenschr, 1991,69:618. 被引量:1
  • 7Ekstrom U, Abrahamson M, Sveger T, et al. Expression of an LDL receptor allele with two different mutations(E256K and I402T) [J]. Mol Pathol, 2000,53(1):31- 36. 被引量:1
  • 8Attman PO, Samuelsson O, Alaupovic P. Diagnosis and classification of dyslipidemia in renal disease[J]. Blood Purif, 1996,14(1):49- 57. 被引量:1
  • 9Noto D, Barbagallo CM, Cascio AL. Lipoprotein(a) levels in relation to albumin concentration in childhod nephrotic syndrome[J]. Kidney Int, 1999,56(6):2433 - 2439. 被引量:1
  • 10Doucet C, Mooser V, Gonbert S, et al. Lipoprotein(a) in the nephrotic syndrome:molecular analysis of Lp(a) and apo(a) fragments in plasma and urine[J]. J Am Soc Nephrol, 2000,11(3):507 - 513. 被引量:1

共引文献1699

同被引文献38

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部